-
Registration & networkingPartnering room30 mins
- Investment Summit
Registration
-
Partnering room10 mins
- Investment Summit
A VC leader or industry analyst to set the tone, covering the investment climate for advanced therapies, emerging hotspots and why early-stage innovation is still worth investing in
-
Partnering room40 mins
- Investment Summit
Bringing together investors across the funding spectrum (from seed-stage VCs to growth investors) to share what drives decision making in today’s market
)
)
)
)
-
Partnering room25 mins
- Investment Summit
A showcase from 2 early-stage biotech’s outlining not just what they want from funding partners but what they need – mentorship, guidance, expertise and access to networks
)
)
)
)
-
Partnering room20 mins
- Investment Summit
A candid conversation between a biotech founder and their early investor exploring the startup journey
)
)
-
Refreshment & networking breakPartnering room10 mins
- Investment Summit
1-2-1 Meetings
-
Partnering room20 mins
- Investment Summit
)
-
Partnering room25 mins
- Investment Summit
A rapid-fire panel / multi-perspective session on high-growth areas in biotech. Each speaker gives a 5-minute outlook on where their focus and how this aligns with market trends
)
)
)
-
Partnering room5 mins
- Investment Summit
Wrap up from senior VC – covering the landscape of what’s next and where biotech investment will grow for the next 5 years
-
Investment Summit & Women In Advanced Therapies LunchPartnering room55 mins
- Investment Summit
- Women in Advanced Therapies
Lunch break and networking
-
Partnering room5 mins
- Women in Advanced Therapies
Welcome address
-
Partnering room40 mins
- Women in Advanced Therapies
Explore the complex mix of visible and invisible barriers that shape entry into the industry. Address systemic challenges and how we can create a truly inclusive workforce
)
)
)
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
-
Partnering room45 mins
- Women in Advanced Therapies
)
)
)
)
-
Networking breakPartnering room10 mins
- Women in Advanced Therapies
1-2-1 Meetings
-
Partnering room30 mins
- Women in Advanced Therapies
Following on from the earlier roundtables, this session enables the moderator from each table to share the key points from the discussion. Enabling audience members to receive insights across all topics and encouraging further discussion post-event.
-
Partnering room20 mins
- Women in Advanced Therapies
-
Building resilience and strategy crucial for long term success
-
Navigating uncertainty and leading with confidence
-
Owning your leadership style and being a successful leader
-
Partnering room10 mins
- Women in Advanced Therapies
Closing address
-
Drinks reception90 mins
-
60 minsCatapult
-
Exhibition Hall60 mins
-
Plenary10 mins
-
Plenary45 minsThis session will explore the current state of the CGT industry, with a focus on Europe’s evolving role amid global shifts. In a climate where research ecosystems face mounting uncertainty — particularly following moves in the U.S. to scale back federal support for scientific innovation, Europe must sharpen its competitiveness to secure its leadership in advanced therapies. We will examine emerging trends, key market dynamics, and the urgent need for Europe to overcome challenges around scalability, affordability, and patient access. The discussion will highlight how external pressures are reshaping Europe’s strategic priorities — and what actions are needed now to turn today’s challenges into tomorrow’s leadership in CGT.
)
)
)
-
Plenary35 mins
Deep dive into the regulatory framework that governs CGT across major rejoins, focusing on recent updates, new legislation and how companies can navigate the changing landscape.
)
)
-
Coffee and networking breakExhibition Hall30 mins
-
Theatre 11 mins
-
Theatre 21 mins
-
Theatre 130 mins
- R&D, clinical innovation & translation
- Cutting edge developments in CRISPR, gene editing and cell engineering
- The next wave of in vivo and ex vivo gene therapies
- What breakthroughs are expected to reshape the industry?
-
Theatre 230 mins
- Manufacturing, scale up & commercial strategy
-
As the pressure mounts to deliver advanced therapies faster, cheaper, and closer to the patient, decentralised manufacturing is stepping into the spotlight. But does breaking away from centralised models really deliver on cost?
-
This panel dives into the economic realities behind the decentralisation trend. Are localised manufacturing hubs the answer to cutting costs, or do they introduce new layers of complexity and hidden spend? From infrastructure investments to regulatory headaches, we’ll separate financial fact from fiction and explore whether decentralisation is a bold leap forward or an expensive detour.
-
30 mins
Highlight how the UK is strengthening its ATMP ecosystem through coordinated infrastructure, regulatory agility, and health system integration — with a forward-looking, opportunity-driven lens.
)
)
)
)
-
Theatre 120 mins
- R&D, clinical innovation & translation
-
Theatre 220 mins
- Manufacturing, scale up & commercial strategy
)
-
Theatre 120 mins
- R&D, clinical innovation & translation
-
Theatre 220 mins
- Manufacturing, scale up & commercial strategy
-
Theatre 230 mins
- Manufacturing, scale up & commercial strategy
- Balancing technical and financial realities in manufacturing
- When to invest in infrastructure vs outsourcing
- The role of automation in optimising CMC process
-
Theatre 130 mins
- R&D, clinical innovation & translation
-
Why characterisation and analytics remain a major hurdle.
-
Collaborative approaches to tackling technical challenges
-
Best practices and emerging solutions.
-
Spain’s Biotech Leap: Manufacturing, Clinical Capacity & EU Integration30 minsExplore Spain’s growing potential as a strategic ATMP manufacturing and clinical trial hub within the EU.
)
)
)
)
-
Lunch & networking breakExhibition Hall70 mins
-
70 minsCytiva
-
Theatre 130 mins
- R&D, clinical innovation & translation
-
How startups secure investment before reaching human trials
-
strategic and tactical guidance on how to secure the right funding at the right time, from seed rounds through Series A
-
Investor insights into due diligence, risk mitigation and valuation and what good really looks like
-
Theatre 230 mins
- Manufacturing, scale up & commercial strategy
-
Transitioning from academic proof of concept to market-ready product
-
Why biotech teams must integrate CMC, regulatory and pharmacology early
-
Avoiding pitfalls of overselling and overpromising
-
30 mins
Showcase how Nordic countries are combining national strengths in biomanufacturing, data infrastructure, and public-private partnerships to build a regional ATMP hub.
)
)
)
)
)
)
-
Theatre 220 mins
- Manufacturing, scale up & commercial strategy
-
Theatre 120 mins
- R&D, clinical innovation & translation
-
Theatre 120 mins
- R&D, clinical innovation & translation
-
Theatre 220 mins
- Manufacturing, scale up & commercial strategy
-
Coffee break & networkingExhibition Hall15 mins1-2-1 Meetings
-
Plenary60 mins
Our interactive roundtables are designed with you in mind. Dive into dynamic, interactive discussions tailored to your interests. Select the table that sparks your curiosity, engage with like-minded professionals, and be part of a conversation that’s both insightful and impactful.
Topics:
- Overcoming the barriers to scale-up in cell therapy manufacturing
- Scaling allogeneic: Making off-the-shelf cell therapies work – Hosted by: John Campbell, CSO, Swarm Oncology
-
- Priming the Market: What It Really Takes to Launch Advanced Therapies – Hosted by: Mayra Battilani Becegato, EMEA Commercial Director, Johnson & Johnson
- Addressing regulatory bottlenecks for advanced therapies
- The role of AI in therapy development and manufacturing
- Funding strategies for early-stage cell and gene therapy companies. Hosted by: Avencia Snchez-Mejis, CEO & Co-founder, Integra Therapeutics
- Navigating patient access & reimbursement for high-cost therapies
- Investor expectations: what do you need for each funding stage?
- Building the right team – who should be involved at each development stage?
- IP and exclusivity strategies for navigating CGT innovations from conception to commercialization. Hosted by: Jeremiah B. Frueauf Director, Chair of Biotechnology & Chemical Practice Group and Deborah Sterling Director, Sterne Kessler
-
Networking Happy HourExhibition Hall60 mins
-
60 minsCatalent
-
Plenary90 minsJoin us for an exciting session where innovative biotech start-ups pitch their groundbreaking ideas and solutions. Watch as they present to a panel of expert investors, who will provide real-time feedback, insights, and guidance. This is a unique opportunity to explore cutting-edge advancements in the biotech space and gain valuable perspectives from both entrepreneurs and industry leaders.
-
Plenary30 minsToday's CGT startups are facing the toughest fundraising environment in years — and solid science alone isn’t enough. This panel digs into the hard truths: How the market squeeze is reshaping funding dynamics, why traditional playbooks aren't working, and what it takes to stand out when investors are more selective than ever. Real stories. Real setbacks. Real strategies for surviving and scaling in a high-stakes market.
)
-
Networking & coffee breakExhibition Hall30 mins
-
Theatre 11 mins
-
Theatre 21 mins
-
Theatre 220 mins
- Manufacturing, scale up & commercial strategy
-
Theatre 120 mins
- R&D, clinical innovation & translation
)
-
Theatre 135 mins
- R&D, clinical innovation & translation
-
Best practices for early interactions with EMA, FDA, MHRA etc.
-
How proactive regulatory engagement reduces delays and de-risk trials
-
Lessons learned from companies that successfully navigated approval
-
Theatre 235 mins
- Manufacturing, scale up & commercial strategy
-
Explore strategies for securing reimbursement and market access for cell and gene therapies, focusing on pricing, HTAs, and policy advocacy to ensure patient access.
)
)
)
)
-
Lunch breakExhibition Hall60 mins
-
Theatre 120 mins
- R&D, clinical innovation & translation
-
Theatre 220 mins
- Manufacturing, scale up & commercial strategy
-
Theatre 120 mins
- R&D, clinical innovation & translation
-
Theatre 220 mins
- Manufacturing, scale up & commercial strategy
)
-
Exhibition Hall20 mins1-2-1 Meetings
-
Plenary15 mins
-
Plenary45 minsAs we wrap up two days of deep discussions on the current state of the European CGT landscape, this final panel will chart the path ahead. Which steps must Europe take to remain competitive and lead the way in the next 5–10 years? Each panellist will share their key takeaways from the last two days, reflecting on the insights, challenges, and opportunities discussed.
)
-
Plenary10 mins